1. Search Result
Search Result
Results for "

ranitidine

" in MedChemExpress (MCE) Product Catalog:

28

Inhibitors & Agonists

1

Biochemical Assay Reagents

2

Natural
Products

4

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B0693
    Ranitidine
    3 Publications Verification

    Histamine Receptor Metabolic Disease Cancer
    Ranitidine is a potent, selective and orally active histamine H2-receptor antagonist that inhibits gastric secretion. Ranitidine antagonizes Histamine (HY-B1204)-induced increases of the guinea-pig isolated rat atrium and Histamine-induced relaxations of the rat isolated uterine horn, with pA2 values of 7.2 and 6.95, respectively. Ranitidine inhibits breast tumor development and spread in mice .
    Ranitidine
  • HY-B0281A
    Ranitidine hydrochloride
    3 Publications Verification

    Histamine Receptor Metabolic Disease Cancer
    Ranitidine hydrochloride is a potent, selective and orally active histamine H2-receptor antagonist that inhibits gastric secretion. Ranitidine hydrochloride antagonizes Histamine (HY-B1204)-induced increases of the guinea-pig isolated rat atrium and Histamine-induced relaxations of the rat isolated uterine horn, with pA2 values of 7.2 and 6.95, respectively. Ranitidine hydrochloride inhibits breast tumor development and spread in mice .
    Ranitidine hydrochloride
  • HY-W040203

    Biochemical Assay Reagents Others
    Decyl β-D-maltopyranoside is an epithelial permeability enhancer. Decyl β-D-maltopyranoside regulates the paracellular transport pathway and increases the permeability of molecules and proteins transported via the paracellular route. Decyl β-D-maltopyranoside enhances the transepithelial paracellular permeability of EPO across cell monolayers .
    Decyl β-D-maltopyranoside
  • HY-Y0543
    5-Methylfurfural
    1 Publications Verification

    Biochemical Assay Reagents COX Inflammation/Immunology Cancer
    5-Methylfurfural is a chemical that can be utilized as food additive, intermediate in the production of agrochemicals, and precursor of certain anti-cancer natural products. 5-Methylfurfural is formed during the photoexposition of ranitidine hydrochloride. 5-Methylfurfural is an organic compound. 5-Methylfurfural has a strong tendency to be further hydrogenated to 2,5-dimethylfuran (DMF). 5-Methylfurfural can predominantly evoke skin inflammation and barrier disintegration. 5-Methylfurfural degrades native DNA through the formation of single-strand breaks .
    5-Methylfurfural
  • HY-B0693A

    Histamine Receptor SARS-CoV Bacterial Infection Metabolic Disease Cancer
    Ranitidine bismuth citrate is a potent, selective and orally active histamine H2-receptor antagonist that inhibits gastric secretion. Ranitidine bismuth citrate antagonizes Histamine (HY-B1204)-induced increases of the guinea-pig isolated rat atrium and Histamine-induced relaxations of the rat isolated uterine horn, with pA2 values of 7.2 and 6.95, respectively. Ranitidine bismuth citrate has selectivity for SARS-CoV-2-infected cells. Ranitidine bismuth citrate also has anti-Helicobacter pylori infection. Ranitidine bismuth citrate inhibits breast tumor development and spread in mice .
    Ranitidine bismuth citrate
  • HY-W011245

    Drug Metabolite Metabolic Disease
    Ranitidine S-oxide is the metabolite of Ranitidine (HY-B0693). Ranitidine is a potent, selective and orally active histamine H2-receptor antagonist with an IC50 of 3.3 μM that inhibits gastric secretion .
    Ranitidine S-oxide
  • HY-W011245R

    Reference Standards Drug Metabolite Metabolic Disease
    Ranitidine S-oxide (Standard) is the analytical standard of Ranitidine S-oxide. This product is intended for research and analytical applications. Ranitidine S-oxide is the metabolite of Ranitidine (HY-B0693). Ranitidine is a potent, selective and orally active histamine H2-receptor antagonist with an IC50 of 3.3 μM that inhibits gastric secretion .
    Ranitidine S-oxide (Standard)
  • HY-B0281AR

    Reference Standards Histamine Receptor Metabolic Disease Cancer
    Ranitidine hydrochloride (Standard) is the analytical standard of Ranitidine hydrochloride (HY-B0281A). This product is intended for research and analytical applications. Ranitidine hydrochloride is a potent, selective and orally active histamine H2-receptor antagonist that inhibits gastric secretion. Ranitidine hydrochloride antagonizes Histamine (HY-B1204)-induced increases of the guinea-pig isolated rat atrium and Histamine-induced relaxations of the rat isolated uterine horn, with pA2 values of 7.2 and 6.95, respectively. Ranitidine hydrochloride inhibits breast tumor development and spread in mice.
    Ranitidine hydrochloride (Standard)
  • HY-B0281AS

    Isotope-Labeled Compounds Histamine Receptor Metabolic Disease Cancer
    Ranitidine-d6 hydrochloride is the deuterium labeled Ranitidine hydrochloride (HY-B0281A) . Ranitidine hydrochloride is a potent, selective and orally active histamine H2-receptor antagonist that inhibits gastric secretion. Ranitidine hydrochloride antagonizes Histamine (HY-B1204)-induced increases of the guinea-pig isolated rat atrium and Histamine-induced relaxations of the rat isolated uterine horn, with pA2 values of 7.2 and 6.95, respectively. Ranitidine hydrochloride inhibits breast tumor development and spread in mice .
    Ranitidine-d6 hydrochloride
  • HY-B0693S

    Isotope-Labeled Compounds Histamine Receptor Cancer
    Ranitidine-d6 is the deuterium labeled Ranitidine (HY-B0693). Ranitidine is a potent, selective and orally active histamine H2-receptor antagonist that inhibits gastric secretion. Ranitidine antagonizes Histamine (HY-B1204)-induced increases of the guinea-pig isolated rat atrium and Histamine-induced relaxations of the rat isolated uterine horn, with pA2 values of 7.2 and 6.95, respectively. Ranitidine inhibits breast tumor development and spread in mice .
    Ranitidine-d6
  • HY-Z8387

    ranitidine impurity I

    Drug Intermediate Others
    Ranitidine impurity 2 (Ranitidine impurity I) is an impurity of Ranitidine.
    Ranitidine impurity 2
  • HY-Z8388

    ranitidine impurity J

    Drug Intermediate Others
    Ranitidine impurity 3 (Ranitidine impurity J) is an impurity of Ranitidine.
    Ranitidine impurity 3
  • HY-W013109

    Drug Intermediate Others
    Ranitidine impurity 15 is an impurity of Ranitidine.
    Ranitidine impurity 15
  • HY-W015620

    Drug Intermediate Others
    Ranitidine impurity 14 is an impurity of Ranitidine.
    Ranitidine impurity 14
  • HY-Z6359

    Drug Intermediate Others
    Ranitidine impurity 4 hydrochloride is an impurity of Ranitidine hydrochloride.
    Ranitidine impurity 4 hydrochloride
  • HY-Z2616

    Drug Intermediate Others
    Ranitidine impurity 4 is an impurity of Ranitidine.
    Ranitidine impurity 4
  • HY-W702661

    Drug Intermediate Others
    Ranitidine impurity 13 is an impurity of Ranitidine.
    Ranitidine impurity 13
  • HY-Z2517

    Drug Intermediate Others
    Ranitidine impurity 8 is an impurity of Ranitidine.
    Ranitidine impurity 8
  • HY-126875

    Drug Intermediate Others
    Ranitidine impurity 12 is an impurity of Ranitidine.
    Ranitidine impurity 12
  • HY-Z1899

    Drug Intermediate Others
    Ranitidine impurity 11 is an impurity of Ranitidine.
    Ranitidine impurity 11
  • HY-Y0543R

    Biochemical Assay Reagents Reference Standards COX Inflammation/Immunology Cancer
    5-Methylfurfural (Standard) is the analytical standard of 5-Methylfurfural. This product is intended for research and analytical applications. 5-Methylfurfural is a chemical that can be utilized as food additive, intermediate in the production of agrochemicals, and precursor of certain anti-cancer natural products. 5-Methylfurfural is formed during the photoexposition of ranitidine hydrochloride. 5-Methylfurfural is an organic compound. 5-Methylfurfural has a strong tendency to be further hydrogenated to 2,5-dimethylfuran (DMF). 5-Methylfurfural can predominantly evoke skin inflammation and barrier disintegration. 5-Methylfurfural degrades native DNA through the formation of single-strand breaks .
    5-Methylfurfural (Standard)
  • HY-136818

    Histamine Receptor Endocrinology
    DA 4643 (hydrochloride) is an H2 receptor antagonist with the chemical name 2-guanidino-4 (3-methylaminomethyleneiminophenyl) thiazole dihydrochloride. It has a weak interaction with cytochrome P-450 and has a less inhibitory effect on P-450 than cimetidine and tiotidine. DA 4643 (hydrochloride) is able to inhibit both enzymatic and non-enzymatic lipid peroxidation reactions. This inhibition may not be achieved by inhibiting agent metabolizing enzymes, but rather due to the antioxidant properties of the compound itself. Compared with other H2 receptor antagonists such as cimetidine, ranitidine and tiotidine, DA 4643 (hydrochloride) shows a unique effect in lipid peroxidation inhibition. These properties make DA 4643 (hydrochloride) a potential H2 receptor antagonist with multiple mechanisms of action.
    DA 4643 dihydrochloride
  • HY-Z8386

    N-Methylnitroacetamide

    Drug Intermediate Others
    Ranitidine impurity 1 (N-Methylnitroacetamide) is an impurity of Ranitidine.
    Ranitidine impurity 1
  • HY-W739861

    1'-Hydroxytriazolam

    Endogenous Metabolite Others
    α-Hydroxytriazolam (1'-Hydroxytriazolam) is a major metabolite of ranitidine (HY-B0693) .
    α-Hydroxytriazolam
  • HY-W711197

    Isotope-Labeled Compounds Others
    2,2'-Methylene Bis[Ranitidine]-d12 is the deuterium labeled (1Z,4Z)-N1,N5-Bis(2-(((5-((dimethylamino)methyl)furan-2-yl)methyl)thio)ethyl)-N1,N5-dimethyl-2,4-dinitropenta-1,4-diene-1,1,5,5-tetraamine (Ranitidine Impurity) (HY-Z8387).
    2,2'-Methylene Bis[Ranitidine]-d12
  • HY-W1040921

    Drug Derivative Inflammation/Immunology
    AY-31574 is a 3, 5-difluoro derivative and selective mucosal protectant. AY-31574 is equipotent with Ranitidine (HY-B0693) against gastric injury caused by stress .
    AY-31574
  • HY-W700730

    Isotope-Labeled Compounds Others
    5-[(Dimethyl-amino)methyl]-2-furanmethanol-d6 is the deuterium labeled (5-((dimethylamino)methyl)furan-2-yl)methanol (Ranitidine Impurity) (HY-Z2616).
    5-[(Dimethyl-amino)methyl]-2-furanmethanol-d6
  • HY-182427

    Histamine Receptor Inflammation/Immunology
    ORF 17583 is a Ranitidine (HY-B0693) analogue and H2 receptor antagonist. ORF 17583 exhibits typical reversible competitive antagonism in the guinea pig right atria model, causing a dose-dependent rightward shift of the histamine concentration-response curve without reducing the maximum effect, and its action is fully reversible upon washing. ORF 17583 can be used for research on peptic ulcers and hyperacidity .
    ORF 17583

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: